These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7792972)

  • 1. [Identification of cancer genes. The need for diagnosis and counseling of families with cancer].
    Brøndum-Nielsen K; Tommerup N
    Ugeskr Laeger; 1995 Jun; 157(24):3462-3. PubMed ID: 7792972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identification of cancer genes has made the testing of predisposition possible. Genetic counseling and mutation screening can result in new therapeutic methods].
    Nordenskjöld M
    Lakartidningen; 1999 Aug; 96(32-33):3392-6. PubMed ID: 10479788
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
    Shah MR
    Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specialized genetic counseling in pediatric and adult oncology patients].
    Krutílková V; Havlovicová M; Goetz P
    Cas Lek Cesk; 2002; 141(1):23-7. PubMed ID: 11899542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
    Henriksson K; Olsson H; Kristoffersson U
    Acta Oncol; 2004; 43(7):637-49. PubMed ID: 15545184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
    Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
    CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing and the family.
    Van Riper M
    J Midwifery Womens Health; 2005; 50(3):227-33. PubMed ID: 15895001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inherited breast and ovarian cancers].
    Gerdes AM; Ejlertsen B
    Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Europe to pay royalties for cancer gene.
    Abbott A
    Nature; 2008 Dec; 456(7222):556. PubMed ID: 19052591
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA diagnosis and the emergence of cancer genetic services in European health care.
    Stemerding D; Koch L; Bourret P
    Eur J Hum Genet; 1997; 5 Suppl 2():25-30. PubMed ID: 9450191
    [No Abstract]   [Full Text] [Related]  

  • 15. Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast/ovarian cancer families.
    Díez O; Gutiérrez-Enríquez S; Ramón y Cajal T; Alonso C; Balmaña J; Llort G
    J Clin Oncol; 2007 Nov; 25(31):5035-6; author reply 5036-8. PubMed ID: 17971607
    [No Abstract]   [Full Text] [Related]  

  • 16. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG; Doan B; Kelner M; Taylor KM
    CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic tests forge ahead, despite scientific concerns.
    Marshall A
    Nat Biotechnol; 1996 Dec; 14(13):1642-3. PubMed ID: 9634835
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
    Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
    Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic testing for cancer susceptibility: the present situation in Japan].
    Miki Y
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):930-7. PubMed ID: 9212800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.